CGRP, Human (Eptinezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CGRP, Human (Eptinezumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCGRP, Human (Eptinezumab biosimilar)
CloneEptinezumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, IHC, IF, IP, FCM, Inhib
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CGRP Recombinant Antibody (Eptinezumab). Eptinezumab, sold under the brand name Vyepti, is a medication for the preventive treatment of migraine in adults. It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta. It is administered by intravenous infusion every three months. Eptinezumab-jjmr was approved for use in the United States in February 2020.
Immunogenn/a
Other NamesAnti-CGRP Recombinant Antibody, Research Grade Eptinezumab, Anti-Human CGRP Recombinant Antibody(Eptinezumab), ALD-403, Antibody Drug Analogues, Monoclonal Antibody, YR1428, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1644539-04-7
Catalog #YR1428
Priceplease inquire
Order / More InfoCGRP, Human (Eptinezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.